Do EU5 Countries with Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?
Abstract
Authors
G Allen A Hall K Hanman R Le Fevre A Griffiths
G Allen A Hall K Hanman R Le Fevre A Griffiths
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now